Global and United States Diabetic Peripheral Neuropathy Treatment Market Size, Status and Forecast 2021-2027

Global and United States Diabetic Peripheral Neuropathy Treatment Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetic Peripheral Neuropathy Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antimunocel
1.2.3 ASP-8477
1.2.4 BNV-222
1.2.5 Capsaicin
1.2.6 CBX-129801
1.2.7 Others
1.3 Market by Application
1.3.1 Global Diabetic Peripheral Neuropathy Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Diabetic Peripheral Neuropathy Treatment Market Perspective (2016-2027)
2.2 Diabetic Peripheral Neuropathy Treatment Growth Trends by Regions
2.2.1 Diabetic Peripheral Neuropathy Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diabetic Peripheral Neuropathy Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Diabetic Peripheral Neuropathy Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Diabetic Peripheral Neuropathy Treatment Industry Dynamic
2.3.1 Diabetic Peripheral Neuropathy Treatment Market Trends
2.3.2 Diabetic Peripheral Neuropathy Treatment Market Drivers
2.3.3 Diabetic Peripheral Neuropathy Treatment Market Challenges
2.3.4 Diabetic Peripheral Neuropathy Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetic Peripheral Neuropathy Treatment Players by Revenue
3.1.1 Global Top Diabetic Peripheral Neuropathy Treatment Players by Revenue (2016-2021)
3.1.2 Global Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Diabetic Peripheral Neuropathy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diabetic Peripheral Neuropathy Treatment Revenue
3.4 Global Diabetic Peripheral Neuropathy Treatment Market Concentration Ratio
3.4.1 Global Diabetic Peripheral Neuropathy Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetic Peripheral Neuropathy Treatment Revenue in 2020
3.5 Diabetic Peripheral Neuropathy Treatment Key Players Head office and Area Served
3.6 Key Players Diabetic Peripheral Neuropathy Treatment Product Solution and Service
3.7 Date of Enter into Diabetic Peripheral Neuropathy Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetic Peripheral Neuropathy Treatment Breakdown Data by Type
4.1 Global Diabetic Peripheral Neuropathy Treatment Historic Market Size by Type (2016-2021)
4.2 Global Diabetic Peripheral Neuropathy Treatment Forecasted Market Size by Type (2022-2027)
5 Diabetic Peripheral Neuropathy Treatment Breakdown Data by Application
5.1 Global Diabetic Peripheral Neuropathy Treatment Historic Market Size by Application (2016-2021)
5.2 Global Diabetic Peripheral Neuropathy Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Diabetic Peripheral Neuropathy Treatment Market Size (2016-2027)
6.2 North America Diabetic Peripheral Neuropathy Treatment Market Size by Type
6.2.1 North America Diabetic Peripheral Neuropathy Treatment Market Size by Type (2016-2021)
6.2.2 North America Diabetic Peripheral Neuropathy Treatment Market Size by Type (2022-2027)
6.2.3 North America Diabetic Peripheral Neuropathy Treatment Market Size by Type (2016-2027)
6.3 North America Diabetic Peripheral Neuropathy Treatment Market Size by Application
6.3.1 North America Diabetic Peripheral Neuropathy Treatment Market Size by Application (2016-2021)
6.3.2 North America Diabetic Peripheral Neuropathy Treatment Market Size by Application (2022-2027)
6.3.3 North America Diabetic Peripheral Neuropathy Treatment Market Size by Application (2016-2027)
6.4 North America Diabetic Peripheral Neuropathy Treatment Market Size by Country
6.4.1 North America Diabetic Peripheral Neuropathy Treatment Market Size by Country (2016-2021)
6.4.2 North America Diabetic Peripheral Neuropathy Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Diabetic Peripheral Neuropathy Treatment Market Size (2016-2027)
7.2 Europe Diabetic Peripheral Neuropathy Treatment Market Size by Type
7.2.1 Europe Diabetic Peripheral Neuropathy Treatment Market Size by Type (2016-2021)
7.2.2 Europe Diabetic Peripheral Neuropathy Treatment Market Size by Type (2022-2027)
7.2.3 Europe Diabetic Peripheral Neuropathy Treatment Market Size by Type (2016-2027)
7.3 Europe Diabetic Peripheral Neuropathy Treatment Market Size by Application
7.3.1 Europe Diabetic Peripheral Neuropathy Treatment Market Size by Application (2016-2021)
7.3.2 Europe Diabetic Peripheral Neuropathy Treatment Market Size by Application (2022-2027)
7.3.3 Europe Diabetic Peripheral Neuropathy Treatment Market Size by Application (2016-2027)
7.4 Europe Diabetic Peripheral Neuropathy Treatment Market Size by Country
7.4.1 Europe Diabetic Peripheral Neuropathy Treatment Market Size by Country (2016-2021)
7.4.2 Europe Diabetic Peripheral Neuropathy Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Size (2016-2027)
8.2 Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Size by Type
8.2.1 Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Size by Application
8.3.1 Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Size by Region
8.4.1 Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Diabetic Peripheral Neuropathy Treatment Market Size (2016-2027)
9.2 Latin America Diabetic Peripheral Neuropathy Treatment Market Size by Type
9.2.1 Latin America Diabetic Peripheral Neuropathy Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Diabetic Peripheral Neuropathy Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Diabetic Peripheral Neuropathy Treatment Market Size by Type (2016-2027)
9.3 Latin America Diabetic Peripheral Neuropathy Treatment Market Size by Application
9.3.1 Latin America Diabetic Peripheral Neuropathy Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Diabetic Peripheral Neuropathy Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Diabetic Peripheral Neuropathy Treatment Market Size by Application (2016-2027)
9.4 Latin America Diabetic Peripheral Neuropathy Treatment Market Size by Country
9.4.1 Latin America Diabetic Peripheral Neuropathy Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Diabetic Peripheral Neuropathy Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Size (2016-2027)
10.2 Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Size by Type
10.2.1 Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Size by Application
10.3.1 Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Size by Country
10.4.1 Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Achelios Therapeutics Inc
11.1.1 Achelios Therapeutics Inc Company Details
11.1.2 Achelios Therapeutics Inc Business Overview
11.1.3 Achelios Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Introduction
11.1.4 Achelios Therapeutics Inc Revenue in Diabetic Peripheral Neuropathy Treatment Business (2016-2021)
11.1.5 Achelios Therapeutics Inc Recent Development
11.2 Celgene Corp
11.2.1 Celgene Corp Company Details
11.2.2 Celgene Corp Business Overview
11.2.3 Celgene Corp Diabetic Peripheral Neuropathy Treatment Introduction
11.2.4 Celgene Corp Revenue in Diabetic Peripheral Neuropathy Treatment Business (2016-2021)
11.2.5 Celgene Corp Recent Development
11.3 Commence Bio Inc
11.3.1 Commence Bio Inc Company Details
11.3.2 Commence Bio Inc Business Overview
11.3.3 Commence Bio Inc Diabetic Peripheral Neuropathy Treatment Introduction
11.3.4 Commence Bio Inc Revenue in Diabetic Peripheral Neuropathy Treatment Business (2016-2021)
11.3.5 Commence Bio Inc Recent Development
11.4 Grunenthal GmbH
11.4.1 Grunenthal GmbH Company Details
11.4.2 Grunenthal GmbH Business Overview
11.4.3 Grunenthal GmbH Diabetic Peripheral Neuropathy Treatment Introduction
11.4.4 Grunenthal GmbH Revenue in Diabetic Peripheral Neuropathy Treatment Business (2016-2021)
11.4.5 Grunenthal GmbH Recent Development
11.5 Immune Pharmaceuticals Inc
11.5.1 Immune Pharmaceuticals Inc Company Details
11.5.2 Immune Pharmaceuticals Inc Business Overview
11.5.3 Immune Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Introduction
11.5.4 Immune Pharmaceuticals Inc Revenue in Diabetic Peripheral Neuropathy Treatment Business (2016-2021)
11.5.5 Immune Pharmaceuticals Inc Recent Development
11.6 KPI Therapeutics Inc
11.6.1 KPI Therapeutics Inc Company Details
11.6.2 KPI Therapeutics Inc Business Overview
11.6.3 KPI Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Introduction
11.6.4 KPI Therapeutics Inc Revenue in Diabetic Peripheral Neuropathy Treatment Business (2016-2021)
11.6.5 KPI Therapeutics Inc Recent Development
11.7 Medifron DBT Co Ltd
11.7.1 Medifron DBT Co Ltd Company Details
11.7.2 Medifron DBT Co Ltd Business Overview
11.7.3 Medifron DBT Co Ltd Diabetic Peripheral Neuropathy Treatment Introduction
11.7.4 Medifron DBT Co Ltd Revenue in Diabetic Peripheral Neuropathy Treatment Business (2016-2021)
11.7.5 Medifron DBT Co Ltd Recent Development
11.8 Mitsubishi Tanabe Pharma Corp
11.8.1 Mitsubishi Tanabe Pharma Corp Company Details
11.8.2 Mitsubishi Tanabe Pharma Corp Business Overview
11.8.3 Mitsubishi Tanabe Pharma Corp Diabetic Peripheral Neuropathy Treatment Introduction
11.8.4 Mitsubishi Tanabe Pharma Corp Revenue in Diabetic Peripheral Neuropathy Treatment Business (2016-2021)
11.8.5 Mitsubishi Tanabe Pharma Corp Recent Development
11.9 Novaremed Ltd
11.9.1 Novaremed Ltd Company Details
11.9.2 Novaremed Ltd Business Overview
11.9.3 Novaremed Ltd Diabetic Peripheral Neuropathy Treatment Introduction
11.9.4 Novaremed Ltd Revenue in Diabetic Peripheral Neuropathy Treatment Business (2016-2021)
11.9.5 Novaremed Ltd Recent Development
11.10 Reata Pharmaceuticals Inc
11.10.1 Reata Pharmaceuticals Inc Company Details
11.10.2 Reata Pharmaceuticals Inc Business Overview
11.10.3 Reata Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Introduction
11.10.4 Reata Pharmaceuticals Inc Revenue in Diabetic Peripheral Neuropathy Treatment Business (2016-2021)
11.10.5 Reata Pharmaceuticals Inc Recent Development
11.11 Relief Therapeutics Holding AG
11.11.1 Relief Therapeutics Holding AG Company Details
11.11.2 Relief Therapeutics Holding AG Business Overview
11.11.3 Relief Therapeutics Holding AG Diabetic Peripheral Neuropathy Treatment Introduction
11.11.4 Relief Therapeutics Holding AG Revenue in Diabetic Peripheral Neuropathy Treatment Business (2016-2021)
11.11.5 Relief Therapeutics Holding AG Recent Development
11.12 ViroMed Co Ltd
11.12.1 ViroMed Co Ltd Company Details
11.12.2 ViroMed Co Ltd Business Overview
11.12.3 ViroMed Co Ltd Diabetic Peripheral Neuropathy Treatment Introduction
11.12.4 ViroMed Co Ltd Revenue in Diabetic Peripheral Neuropathy Treatment Business (2016-2021)
11.12.5 ViroMed Co Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Diabetic Peripheral Neuropathy Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antimunocel
Table 3. Key Players of ASP-8477
Table 4. Key Players of BNV-222
Table 5. Key Players of Capsaicin
Table 6. Key Players of CBX-129801
Table 7. Key Players of Others
Table 8. Global Diabetic Peripheral Neuropathy Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Diabetic Peripheral Neuropathy Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Diabetic Peripheral Neuropathy Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Diabetic Peripheral Neuropathy Treatment Market Share by Regions (2016-2021)
Table 12. Global Diabetic Peripheral Neuropathy Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Diabetic Peripheral Neuropathy Treatment Market Share by Regions (2022-2027)
Table 14. Diabetic Peripheral Neuropathy Treatment Market Trends
Table 15. Diabetic Peripheral Neuropathy Treatment Market Drivers
Table 16. Diabetic Peripheral Neuropathy Treatment Market Challenges
Table 17. Diabetic Peripheral Neuropathy Treatment Market Restraints
Table 18. Global Diabetic Peripheral Neuropathy Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Diabetic Peripheral Neuropathy Treatment Market Share by Players (2016-2021)
Table 20. Global Top Diabetic Peripheral Neuropathy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Peripheral Neuropathy Treatment as of 2020)
Table 21. Ranking of Global Top Diabetic Peripheral Neuropathy Treatment Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Diabetic Peripheral Neuropathy Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Diabetic Peripheral Neuropathy Treatment Product Solution and Service
Table 25. Date of Enter into Diabetic Peripheral Neuropathy Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Diabetic Peripheral Neuropathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Type (2016-2021)
Table 29. Global Diabetic Peripheral Neuropathy Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Diabetic Peripheral Neuropathy Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Application (2016-2021)
Table 33. Global Diabetic Peripheral Neuropathy Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Diabetic Peripheral Neuropathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Diabetic Peripheral Neuropathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Diabetic Peripheral Neuropathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Diabetic Peripheral Neuropathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Diabetic Peripheral Neuropathy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Diabetic Peripheral Neuropathy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Diabetic Peripheral Neuropathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Diabetic Peripheral Neuropathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Diabetic Peripheral Neuropathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Diabetic Peripheral Neuropathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Diabetic Peripheral Neuropathy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Diabetic Peripheral Neuropathy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Diabetic Peripheral Neuropathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Diabetic Peripheral Neuropathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Diabetic Peripheral Neuropathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Diabetic Peripheral Neuropathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Diabetic Peripheral Neuropathy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Diabetic Peripheral Neuropathy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 65. Achelios Therapeutics Inc Company Details
Table 66. Achelios Therapeutics Inc Business Overview
Table 67. Achelios Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Product
Table 68. Achelios Therapeutics Inc Revenue in Diabetic Peripheral Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 69. Achelios Therapeutics Inc Recent Development
Table 70. Celgene Corp Company Details
Table 71. Celgene Corp Business Overview
Table 72. Celgene Corp Diabetic Peripheral Neuropathy Treatment Product
Table 73. Celgene Corp Revenue in Diabetic Peripheral Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 74. Celgene Corp Recent Development
Table 75. Commence Bio Inc Company Details
Table 76. Commence Bio Inc Business Overview
Table 77. Commence Bio Inc Diabetic Peripheral Neuropathy Treatment Product
Table 78. Commence Bio Inc Revenue in Diabetic Peripheral Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 79. Commence Bio Inc Recent Development
Table 80. Grunenthal GmbH Company Details
Table 81. Grunenthal GmbH Business Overview
Table 82. Grunenthal GmbH Diabetic Peripheral Neuropathy Treatment Product
Table 83. Grunenthal GmbH Revenue in Diabetic Peripheral Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 84. Grunenthal GmbH Recent Development
Table 85. Immune Pharmaceuticals Inc Company Details
Table 86. Immune Pharmaceuticals Inc Business Overview
Table 87. Immune Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Product
Table 88. Immune Pharmaceuticals Inc Revenue in Diabetic Peripheral Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 89. Immune Pharmaceuticals Inc Recent Development
Table 90. KPI Therapeutics Inc Company Details
Table 91. KPI Therapeutics Inc Business Overview
Table 92. KPI Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Product
Table 93. KPI Therapeutics Inc Revenue in Diabetic Peripheral Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 94. KPI Therapeutics Inc Recent Development
Table 95. Medifron DBT Co Ltd Company Details
Table 96. Medifron DBT Co Ltd Business Overview
Table 97. Medifron DBT Co Ltd Diabetic Peripheral Neuropathy Treatment Product
Table 98. Medifron DBT Co Ltd Revenue in Diabetic Peripheral Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 99. Medifron DBT Co Ltd Recent Development
Table 100. Mitsubishi Tanabe Pharma Corp Company Details
Table 101. Mitsubishi Tanabe Pharma Corp Business Overview
Table 102. Mitsubishi Tanabe Pharma Corp Revenue in Diabetic Peripheral Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 103. Mitsubishi Tanabe Pharma Corp Recent Development
Table 104. Novaremed Ltd Company Details
Table 105. Novaremed Ltd Business Overview
Table 106. Novaremed Ltd Diabetic Peripheral Neuropathy Treatment Product
Table 107. Novaremed Ltd Revenue in Diabetic Peripheral Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 108. Novaremed Ltd Recent Development
Table 109. Reata Pharmaceuticals Inc Company Details
Table 110. Reata Pharmaceuticals Inc Business Overview
Table 111. Reata Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Product
Table 112. Reata Pharmaceuticals Inc Revenue in Diabetic Peripheral Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 113. Reata Pharmaceuticals Inc Recent Development
Table 114. Relief Therapeutics Holding AG Company Details
Table 115. Relief Therapeutics Holding AG Business Overview
Table 116. Relief Therapeutics Holding AG Diabetic Peripheral Neuropathy Treatment Product
Table 117. Relief Therapeutics Holding AG Revenue in Diabetic Peripheral Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 118. Relief Therapeutics Holding AG Recent Development
Table 119. ViroMed Co Ltd Company Details
Table 120. ViroMed Co Ltd Business Overview
Table 121. ViroMed Co Ltd Diabetic Peripheral Neuropathy Treatment Product
Table 122. ViroMed Co Ltd Revenue in Diabetic Peripheral Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 123. ViroMed Co Ltd Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetic Peripheral Neuropathy Treatment Market Share by Type: 2020 VS 2027
Figure 2. Antimunocel Features
Figure 3. ASP-8477 Features
Figure 4. BNV-222 Features
Figure 5. Capsaicin Features
Figure 6. CBX-129801 Features
Figure 7. Others Features
Figure 8. Global Diabetic Peripheral Neuropathy Treatment Market Share by Application: 2020 VS 2027
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Diabetic Peripheral Neuropathy Treatment Report Years Considered
Figure 13. Global Diabetic Peripheral Neuropathy Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Diabetic Peripheral Neuropathy Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Diabetic Peripheral Neuropathy Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global Diabetic Peripheral Neuropathy Treatment Market Share by Regions (2022-2027)
Figure 17. Global Diabetic Peripheral Neuropathy Treatment Market Share by Players in 2020
Figure 18. Global Top Diabetic Peripheral Neuropathy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Peripheral Neuropathy Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Diabetic Peripheral Neuropathy Treatment Revenue in 2020
Figure 20. Global Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Diabetic Peripheral Neuropathy Treatment Market Share by Type (2016-2027)
Figure 24. North America Diabetic Peripheral Neuropathy Treatment Market Share by Application (2016-2027)
Figure 25. North America Diabetic Peripheral Neuropathy Treatment Market Share by Country (2016-2027)
Figure 26. United States Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Diabetic Peripheral Neuropathy Treatment Market Share by Type (2016-2027)
Figure 30. Europe Diabetic Peripheral Neuropathy Treatment Market Share by Application (2016-2027)
Figure 31. Europe Diabetic Peripheral Neuropathy Treatment Market Share by Country (2016-2027)
Figure 32. Germany Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Share by Region (2016-2027)
Figure 42. China Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Diabetic Peripheral Neuropathy Treatment Market Share by Type (2016-2027)
Figure 50. Latin America Diabetic Peripheral Neuropathy Treatment Market Share by Application (2016-2027)
Figure 51. Latin America Diabetic Peripheral Neuropathy Treatment Market Share by Country (2016-2027)
Figure 52. Mexico Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Share by Country (2016-2027)
Figure 58. Turkey Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Achelios Therapeutics Inc Revenue Growth Rate in Diabetic Peripheral Neuropathy Treatment Business (2016-2021)
Figure 62. Celgene Corp Revenue Growth Rate in Diabetic Peripheral Neuropathy Treatment Business (2016-2021)
Figure 63. Commence Bio Inc Revenue Growth Rate in Diabetic Peripheral Neuropathy Treatment Business (2016-2021)
Figure 64. Grunenthal GmbH Revenue Growth Rate in Diabetic Peripheral Neuropathy Treatment Business (2016-2021)
Figure 65. Immune Pharmaceuticals Inc Revenue Growth Rate in Diabetic Peripheral

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Glycated Albumin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Glycated Albumin market size was valued at US$ 419.7 million in 2023. With growing demand in downstream market, the Glycated Albumin is forecast to a readjusted size of US$ 593.8 million by 2030 with a CAGR of 5.1% during review period. The research report highlights the growth potential of the global Glycated Albumin market. Glycated Albumin are expected to show stable growth in the future market. However, product differenti......

Global Neuropathy Pain Treatment Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Neuropathy Pain Treatment market size was valued at US$ 8341.5 million in 2023. With growing demand in downstream market, the Neuropathy Pain Treatment is forecast to a readjusted size of US$ 10560 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Neuropathy Pain Treatment market. Neuropathy Pain Treatment are expected to show stable growth in the futur......

Global Neuropathy Pain Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 92

According to our (Global Info Research) latest study, the global Neuropathy Pain Treatment market size was valued at USD 8773.9 million in 2023 and is forecast to a readjusted size of USD 10910 million by 2030 with a CAGR of 3.2% during review period. This report studies the Neuropathy Pain Treatment market, Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathy Pain Treatment is used for Neuropathic pain. Global Neuropath......

Global Type 1 Diabetes Therapeutics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Type 1 Diabetes Therapeutics market: According to our latest research, the global Type 1 Diabetes Therapeutics market looks promising in the next 5 years. As of 2022, the global Type 1 Diabetes Therapeutics market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, is a chronic condition in w......

Global Diabetic Neuropathy Professional Survey Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 104

Diabetic neuropathy is a type of nerve damage that can occur if you have diabetes.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are com......

Global Diabetic Neuropathy Market Research Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 2680 Onwards        Pages: 132

Diabetic neuropathy is a type of nerve damage that can occur if you have diabetes.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are com......

Global Diabetic Nephropathy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 23-Nov-2023        Price: US 3380 Onwards        Pages: 122

Market Overview of Global Diabetic Nephropathy market: According to our latest research, the global Diabetic Nephropathy market looks promising in the next 5 years. As of 2022, the global Diabetic Nephropathy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Diabetic nephropathy (DN) is a chronic loss of renal function in diabetic patients. This report covers a research ti......

Global Glycated Albumin Market Research Report 2023, Forecast to 2028

Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 166

Glycated albumin is albumin that has been glycated (bound to sugar). Albumin is the most common type of protein found in blood (~80% of circulating proteins) and is replaced in the body about every 20-25 days. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while ......

Global Glycated Albumin Professional Survey Report 2023, Forecast to 2028

Published: 21-Nov-2023        Price: US 3280 Onwards        Pages: 106

Glycated albumin is albumin that has been glycated (bound to sugar). Albumin is the most common type of protein found in blood (~80% of circulating proteins) and is replaced in the body about every 20-25 days. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs